StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Full-Year Guidance by Quarter

Full-Year Guidance — Estimated reported sales midpoint ($B)

Johnson & Johnson Full-Year Guidance: $101.20B in Q3 2026, up 8.0% from a year earlier. That is the highest of the 17 quarters on record here.

Latest, Q3 2026
101.20
Period ended Sep 30, 2026
Change on a year earlier
+8.0%
93.70 in Q3 2025
History
17 quarters
Since Q3 2022
Sources
17
Documents cited below

Where the Q3 2026 figure comes from

“|| Estimated Reported Sales 3 / Mid-point Change vs. Prior Year / Mid-point | $101.0B – $101.4B / $101.2B 7.2% – 7.6% / 7.4% | $100.8B – $101.4B / $101.1B 7.0% – 7.6% / 7.3%”

Source: Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗

Reported in Form 8-K EX-99.1 Full-Year Guidance Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFull-Year Guidance — Estimated reported sales midpoint ($B)Year on yearSource
Q3 2026Sep 30, 2026101.20+8.0%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 2026101.10+8.2%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 2026100.80+10.3%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 2025100.50+12.2%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 202593.70+5.8%Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2025Jun 29, 202593.40+5.9%Form 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2025Mar 30, 202591.40+3.6%Form 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2024Dec 29, 202489.60+1.6%Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2024Sep 29, 202488.60+5.7%Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2024Jun 30, 202488.20-11.2%Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2024Mar 31, 202488.20-10.4%Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q4 2023Dec 31, 202388.20-9.4%Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗
Q3 2023Oct 1, 202383.80-10.2%Form 8-K (a2023q3exhibit991.htm, filed 2023-10-17) ↗
Q2 2023Jul 2, 202399.30–Form 8-K (a2023q2exhibit991.htm, filed 2023-07-20) ↗
Q1 2023Apr 2, 202398.40–Form 8-K (a2023q1exhibit991.htm, filed 2023-04-18) ↗
Q4 2022Jan 1, 202397.40–Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗

Breakdown

What makes up full-Year Guidance

Cite this data

StockData. (2026). Johnson & Johnson Full-Year Guidance, quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/guid-rep-sales-mid-b

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.